EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 29 filers reported holding EVOKE PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | – | 500 | +2172.7% | 0.00% | – |
| Q1 2016 | $0 | – | 22 | +266.7% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 6 | -99.7% | 0.00% | – |
| Q1 2014 | $17,000 | – | 2,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
| Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
| Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
| STATE STREET CORP | 72,800 | $41,000 | 0.00% |
| MORGAN STANLEY | 9,606 | $5,000 | 0.00% |